The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are: Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis
Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
90
Moxibustion for 10 minutes per acupoint
Moxibustion for 20 minutes per acupoint
Moxibustion for 30 minutes per acupoint
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, China
RECRUITINGRhinitis VAS Visual Analog Scale（AR-VAS）
VAS will be used to evaluate the relief of rhinitis symptoms, with a total score of 0-10. The higher the score, the more severe the symptoms will be
Time frame: Change from baseline VAS scores at week 0(before treatment)，4 and 12.
Total nasal symptom scores（TNSS）
The main symptoms of allergic rhinitis, the higher the score, the worse the condition
Time frame: Change from baseline TNSS scores at week 0(before treatment)，4 and 12.
Total non nasal symptom scores（TNNSS）
The nasal accompanying symptoms of allergic rhinitis, qualitative evaluation of the severity of the disease, with some indicating severity and none indicating milder severity
Time frame: Change from baseline TNNSS scores at week0(before treatment)，4 and 12.
Rhino-conjunctivitis Quality of Life Questionnaire （RQLQ）
RQLQ consists of 28 items, including daily life (1-3), sleep (4-6), non nasal eye symptoms (7-13), life problems (14-16), nasal symptoms (17-20), eye symptoms (21-24), and emotions (25-28). In the 7-point system, 1 point is the best and 7 points are the worst.
Time frame: Change from baseline RQLQ scores at week0(before treatment)，4 and 12.
Detection of serum IgE and IL-33 levels
Immunoglobulin IgE and serum inflammatory cytokine IL-33 levels
Time frame: Week0(before treatment), week 4（after treatment）.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.